NHS AI procurement is no longer a future trend. The volume of AI-related contracts awarded across the NHS and wider public sector has grown consistently year on year, with the UK spending a record-high £1.4 billion on AI in the public sector, so far in 2026. The government has pledged further major investment into artificial intelligence, and NHS England has identified AI as a priority across clinical decision support, diagnostic imaging, administrative automation, and patient communication.

NHS AI procurement is no longer a future trend. The volume of AI-related contracts awarded across the NHS and wider public sector has grown consistently year on year, with the UK spending a record-high £1.4 billion on AI in the public sector, so far in 2026. The government has pledged further major investment into artificial intelligence, and NHS England has identified AI as a priority across clinical decision support, diagnostic imaging, administrative automation, and patient communication.

For suppliers with AI propositions, the commercial question is not whether the NHS is buying AI. It is who the buyers are, which procurement routes they use, and how to position an AI offer in a market that is still developing the frameworks and evaluation criteria to assess it.

For suppliers with AI propositions, the commercial question is not whether the NHS is buying AI. It is who the buyers are, which procurement routes they use, and how to position an AI offer in a market that is still developing the frameworks and evaluation criteria to assess it.

What the NHS is actually buying

NHS AI procurement covers a wide range of capability types, and the route to market, the buyer type, and the evaluation criteria vary significantly between them.

NHS AI procurement covers a wide range of capability types, and the route to market, the buyer type, and the evaluation criteria vary significantly between them.

Clinical AI — Applications that assist diagnosis, triage, or clinical decision-making is subject to the highest regulatory and assurance requirements. Clinical AI tools used in diagnosis or treatment decisions must meet MHRA medical device requirements and in many cases require clinical safety certification under DCB0129. Procurement typically sits with NHS trusts and ICBs, often through NHS SBS clinical technology frameworks or NHS England-managed programmes. Learn more about NHS procurement frameworks and how they work in our guide.

Clinical AI — Applications that assist diagnosis, triage, or clinical decision-making is subject to the highest regulatory and assurance requirements. Clinical AI tools used in diagnosis or treatment decisions must meet MHRA medical device requirements and in many cases require clinical safety certification under DCB0129. Procurement typically sits with NHS trusts and ICBs, often through NHS SBS clinical technology frameworks or NHS England-managed programmes. Learn more about NHS procurement frameworks and how they work in our guide.

AI-enabled administration and workflow — tools that automate coding, scheduling, correspondence, or patient communication, typically carry lighter regulatory requirements and are more accessible to suppliers without clinical certification. These tools often procure through digital and IT frameworks, including G-Cloud lots and NHS SBS digital frameworks.

AI-enabled administration and workflow — tools that automate coding, scheduling, correspondence, or patient communication, typically carry lighter regulatory requirements and are more accessible to suppliers without clinical certification. These tools often procure through digital and IT frameworks, including G-Cloud lots and NHS SBS digital frameworks.

AI-powered analytics and business intelligence — population health analytics, contract management, resource planning are often procured through professional services or data analytics routes rather than clinical technology routes.

AI-powered analytics and business intelligence — population health analytics, contract management, resource planning are often procured through professional services or data analytics routes rather than clinical technology routes.

Understanding which category your AI offer sits in determines which frameworks are relevant, which buyers are the right target, and what assurance evidence you will need to provide. Want to understand which category you fit into and the data you need to identifythe right NHS buyers? Speak to us today.

Understanding which category your AI offer sits in determines which frameworks are relevant, which buyers are the right target, and what assurance evidence you will need to provide. Want to understand which category you fit into and the data you need to identifythe right NHS buyers? Speak to us today.

NHS AI procurement routes

NHS SBS Healthcare AI Solutions

NHS SBS Healthcare AI Solutions

NHS SBS ran preliminary market engagement sessions on its Healthcare AI Solutions framework in March and April 2025, ahead of the tender notice being published on 11 May 2026. The framework is worth £900 million including VAT and runs from May 2027 to May 2035. It covers eight lots: radiology and diagnostic imaging, pathology and preventative healthcare, virtual and robotic health, predictive analytics, research and innovation, operational efficiency, advisory services, and a combined solutions lot for suppliers admitted to two or more other lots.

NHS SBS ran preliminary market engagement sessions on its Healthcare AI Solutions framework in March and April 2025, ahead of the tender notice being published on 11 May 2026. The framework is worth £900 million including VAT and runs from May 2027 to May 2035. It covers eight lots: radiology and diagnostic imaging, pathology and preventative healthcare, virtual and robotic health, predictive analytics, research and innovation, operational efficiency, advisory services, and a combined solutions lot for suppliers admitted to two or more other lots.

The submission deadline was 23 June 2026, with contract awards expected in March 2027. As an open framework, it will reopen to new suppliers at defined intervals after initial award — meaning suppliers who missed the June deadline still have future application windows.

The submission deadline was 23 June 2026, with contract awards expected in March 2027. As an open framework, it will reopen to new suppliers at defined intervals after initial award — meaning suppliers who missed the June deadline still have future application windows.

G-Cloud

G-Cloud

G-Cloud carries significant NHS spend in software and support categories. NHS England spent £23.8 million through G-Cloud 14. For AI software delivered as a cloud service, G-Cloud 15 is an accessible route, particularly for suppliers still building the clinical evidence base needed for larger NHS SBS framework lots. The open framework model of G-Cloud 15 means suppliers who are not listed at launch can apply to join at 18 and 24 months.

G-Cloud carries significant NHS spend in software and support categories. NHS England spent £23.8 million through G-Cloud 14. For AI software delivered as a cloud service, G-Cloud 15 is an accessible route, particularly for suppliers still building the clinical evidence base needed for larger NHS SBS framework lots. The open framework model of G-Cloud 15 means suppliers who are not listed at launch can apply to join at 18 and 24 months.

Get a copy of our exclusive report: 4 Essential Questions Every G-Cloud 15 Supplier Should Answer.

Get a copy of our exclusive report: 4 Essential Questions Every G-Cloud 15 Supplier Should Answer.

NHS England national programmes

NHS England national programmes

Several NHS AI applications have been procured through national NHS England programmes rather than through open tender routes. The Federated Data Platform, AI diagnostics partnerships, and clinical communications infrastructure have all involved national-level procurement decisions that set the terms for how AI is deployed at trust level. Understanding which programmes are active and which are approaching re-procurement is commercially relevant for suppliers whose offer connects to national clinical priorities.

Several NHS AI applications have been procured through national NHS England programmes rather than through open tender routes. The Federated Data Platform, AI diagnostics partnerships, and clinical communications infrastructure have all involved national-level procurement decisions that set the terms for how AI is deployed at trust level. Understanding which programmes are active and which are approaching re-procurement is commercially relevant for suppliers whose offer connects to national clinical priorities.

Spark DPS and innovation routes

Spark DPS and innovation routes

Spark DPS, run by the GCA and endorsed by NHS England for innovation-related procurement, is specifically designed for suppliers that are newer to the NHS market and may not yet have the track record required for established framework lots. It remains open continuously, which means suppliers can apply at any point rather than waiting for a framework window. For AI suppliers in early-stage NHS deployment, the Spark DPS is one of the more accessible compliant routes available.

Spark DPS, run by the GCA and endorsed by NHS England for innovation-related procurement, is specifically designed for suppliers that are newer to the NHS market and may not yet have the track record required for established framework lots. It remains open continuously, which means suppliers can apply at any point rather than waiting for a framework window. For AI suppliers in early-stage NHS deployment, the Spark DPS is one of the more accessible compliant routes available.

Who the buyers are and how they commission

NHS AI procurement does not sit with a single buyer type. The commissioning landscape for AI spans NHS England, ICBs, NHS trusts, and NHS Supply Chain, each with different procurement authority and different relationships with the frameworks above.

NHS AI procurement does not sit with a single buyer type. The commissioning landscape for AI spans NHS England, ICBs, NHS trusts, and NHS Supply Chain, each with different procurement authority and different relationships with the frameworks above.

NHS England commissions at national scale for programmes affecting the whole NHS. Contracts at this level are typically above-threshold and generate formal procurement notices, but the specification is often shaped through significant market engagement that precedes those notices by months.

NHS England commissions at national scale for programmes affecting the whole NHS. Contracts at this level are typically above-threshold and generate formal procurement notices, but the specification is often shaped through significant market engagement that precedes those notices by months.

ICBs commission AI applications at system level, particularly those with a population health or pathway management application. Following the ICB consolidation from 42 to 26 boards, the commissioning landscape is changing, with merged ICBs developing new category strategies and procurement pipelines that reflect the combined priorities of their predecessor organisations. Discover how to get in front of an NHS ICB before they run a procurement.

ICBs commission AI applications at system level, particularly those with a population health or pathway management application. Following the ICB consolidation from 42 to 26 boards, the commissioning landscape is changing, with merged ICBs developing new category strategies and procurement pipelines that reflect the combined priorities of their predecessor organisations. Discover how to get in front of an NHS ICB before they run a procurement.

NHS trusts commission at organisational level, typically for applications that improve their specific operational or clinical performance. Trust-level AI procurement includes both above-threshold contracts that generate visible notices and below-threshold procurement through framework call-offs that may not appear in public tender data.

NHS trusts commission at organisational level, typically for applications that improve their specific operational or clinical performance. Trust-level AI procurement includes both above-threshold contracts that generate visible notices and below-threshold procurement through framework call-offs that may not appear in public tender data.

What makes an NHS AI bid credible

The evaluation of AI bids in NHS procurement has matured significantly over the past three years. Buyers are no longer impressed by capability demonstrations alone. The evidence requirements that determine competitive bids now include several elements that many AI suppliers underestimate.

The evaluation of AI bids in NHS procurement has matured significantly over the past three years. Buyers are no longer impressed by capability demonstrations alone. The evidence requirements that determine competitive bids now include several elements that many AI suppliers underestimate.

Clinical evidence

Clinical evidence

For clinical AI, evidence of clinical effectiveness is now a standard evaluation requirement in most NHS procurement. Peer-reviewed studies, NICE evidence reviews, or published NHS pilot outcomes carry significantly more weight than vendor performance claims.

For clinical AI, evidence of clinical effectiveness is now a standard evaluation requirement in most NHS procurement. Peer-reviewed studies, NICE evidence reviews, or published NHS pilot outcomes carry significantly more weight than vendor performance claims.

Safety and regulatory compliance

Safety and regulatory compliance

MHRA registration where required, clinical safety certification, and information governance compliance are threshold requirements in most NHS AI procurements, not evaluation differentiators. Suppliers who cannot demonstrate compliance are excluded before scoring begins.

MHRA registration where required, clinical safety certification, and information governance compliance are threshold requirements in most NHS AI procurements, not evaluation differentiators. Suppliers who cannot demonstrate compliance are excluded before scoring begins.

Interoperability and integration

Interoperability and integration

NHS trusts and ICBs are under pressure to reduce system fragmentation. An AI tool that requires complex, costly, or proprietary integration with existing NHS systems is a harder commercial proposition than one that integrates with NHS standard infrastructure.

NHS trusts and ICBs are under pressure to reduce system fragmentation. An AI tool that requires complex, costly, or proprietary integration with existing NHS systems is a harder commercial proposition than one that integrates with NHS standard infrastructure.

Deployment evidence at NHS scale

Deployment evidence at NHS scale

A pilot with one trust is useful. Deployments across multiple trusts, in varying clinical environments, and with documented adoption rates and outcomes, is substantially more credible in a competitive evaluation.

A pilot with one trust is useful. Deployments across multiple trusts, in varying clinical environments, and with documented adoption rates and outcomes, is substantially more credible in a competitive evaluation.

Implementation support and ongoing partnership

Implementation support and ongoing partnership

NHS buyers have experienced significant supplier underperformance during implementation phases. Evidence of structured implementation methodology, clinical engagement support, and ongoing customer success is weighted more heavily than it was three years ago.

NHS buyers have experienced significant supplier underperformance during implementation phases. Evidence of structured implementation methodology, clinical engagement support, and ongoing customer success is weighted more heavily than it was three years ago.

How to build a pipeline for NHS AI sales in 4 steps

The commercial approach to NHS AI sales follows the same principles as any NHS procurement pipeline, with one additional consideration: the market is developing faster than the procurement frameworks that support it, which means early engagement with buyers is more commercially valuable than it is in more settled categories.

The commercial approach to NHS AI sales follows the same principles as any NHS procurement pipeline, with one additional consideration: the market is developing faster than the procurement frameworks that support it, which means early engagement with buyers is more commercially valuable than it is in more settled categories.

1. Use spend data to identify which NHS trusts and ICBs are already spending in categories adjacent to your AI application. A trust paying significant amounts to a clinical decision support supplier is a trust that has committed budget to this type of capability and understands what it does. A trust with no spend history in the area requires a longer education process before a commercial conversation can begin.
2. Track NHS SBS framework development and preliminary market engagement notices in your category. The Healthcare AI Solutions framework is the most significant current example, but NHS SBS and NHS England are developing additional AI-adjacent procurement routes. Responding to preliminary market engagement positions your organisation as a credible market participant before specifications are written.
3. Read NHS trust and ICB board papers for references to digital transformation programmes, AI pilots, and clinical technology investments. A trust board paper approving the budget for a clinical AI pilot is a procurement signal that may not appear in a tender notice for twelve months.
4. Map your clinical evidence against the frameworks and evaluation criteria relevant to your category. The assurance requirements for NHS AI procurement are demanding and take time to meet. Understanding what is required before an application window opens is the difference between qualifying and missing the window. See our guide to how to get on an NHS framework for the general application process.

Arcamus tracks NHS contract awards, spend data, and framework intelligence across clinical technology, digital health, and AI categories, so suppliers building an NHS AI pipeline can see where spend is flowing and which buyers are actively investing. Find NHS buyers in your category.

Arcamus tracks NHS contract awards, spend data, and framework intelligence across clinical technology, digital health, and AI categories, so suppliers building an NHS AI pipeline can see where spend is flowing and which buyers are actively investing. Find NHS buyers in your category.